Stock Information
Summit Therapeutics Inc (SMMT)
Ticker Symbol: SMMT
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $11,696.77 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -1.6038
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -291.24%
Latest News
-
Summit Therapeutics Withdraws Previously Announced Proposed $500M Underwritten Public Offering Of Shares Due To Market Conditions
Thu, Jun 11, 2026 7:55 AM
-
Oil Jumps On Iran Strikes, Nasdaq 100 Falls On Hot Inflation: Stock Market Today
Wed, Jun 10, 2026 1:13 PM
-
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Wed, Jun 10, 2026 8:03 AM
-
12 Health Care Stocks Moving In Tuesday's After-Market Session
Tue, Jun 9, 2026 5:06 PM
-
Summit Therapeutics Launches $500M Public Stock Offering To Fund Ivonescimab Development
Tue, Jun 9, 2026 4:48 PM
-
Summit Therapeutics Files For Mixed Shelf Offering; Size Not Disclosed
Tue, Jun 9, 2026 4:36 PM
-
Emergent BioSolutions: Down 40%+ From Recent Highs And Likely More To Come
Mon, Jun 8, 2026 5:27 PM
-
Summit Therapeutics Inc. (SMMT) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Mon, Jun 8, 2026 3:08 PM
Key Financials
Financial data not available
